Lexeo Therapeutics (LXEO) Short-term Investments (2024 - 2026)

Lexeo Therapeutics' Short-term Investments history runs 3 years deep, the most recent figure standing at $121.3 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 71.01% year-over-year to $121.3 million; the TTM figure through Mar 2026 stood at $121.3 million (up 71.01% YoY), while the FY2025 annual figure was $118.8 million, up 37.3% from the prior year.
• Short-term Investments came in at $121.3 million for Q1 2026 at Lexeo Therapeutics, up from $118.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $121.3 million in Q1 2026 to a low of $70.9 million in Q1 2025.
• A 3-year average of $96.1 million and a median of $92.0 million in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 37.3% in 2025 and surged 71.01% in 2026, its largest moves.
• Lexeo Therapeutics' Short-term Investments stood at $86.5 million in 2024, then soared by 37.3% to $118.8 million in 2025, then climbed by 2.11% to $121.3 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $121.3 million, $118.8 million, and $81.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison